Substantially Purified Tumor Growth Inhibitory Factor Read more about Substantially Purified Tumor Growth Inhibitory Factor Japan1985-084353Filed on 1985-04-19
Substantially Purified Tumor Growth Inhibitory Factor Read more about Substantially Purified Tumor Growth Inhibitory Factor Italy85400784.6Filed on 1985-04-19
Substantially Purified Tumor Growth Inhibitory Factor Read more about Substantially Purified Tumor Growth Inhibitory Factor The Netherlands85400784.6Filed on 1985-04-19
Antineoplastic Platinum (IV) Complexes and Compositions Read more about Antineoplastic Platinum (IV) Complexes and Compositions Switzerland85400372.0Filed on 1985-03-01
CELL MATRIX RECEPTOR SYSTEM AND USE IN CANCER DIAGNOSIS AND MANAGEMENT Read more about CELL MATRIX RECEPTOR SYSTEM AND USE IN CANCER DIAGNOSIS AND MANAGEMENT Japan1993-291328Filed on 1993-10-27
CELL MATRIX RECEPTOR SYSTEM AND USE IN CANCER DIAGNOSIS AND MANAGEMENT Read more about CELL MATRIX RECEPTOR SYSTEM AND USE IN CANCER DIAGNOSIS AND MANAGEMENT Japan1984-501642Filed on 1984-04-04
CELL MATRIX RECEPTOR SYSTEM AND USE IN CANCER DIAGNOSIS AND MANAGEMENT Read more about CELL MATRIX RECEPTOR SYSTEM AND USE IN CANCER DIAGNOSIS AND MANAGEMENT Finland844753Filed on 1984-04-04
CELL MATRIX RECEPTOR SYSTEM AND USE IN CANCER DIAGNOSIS AND MANAGEMENT Read more about CELL MATRIX RECEPTOR SYSTEM AND USE IN CANCER DIAGNOSIS AND MANAGEMENT Canada451278Filed on 1984-04-04
NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN NY ESO-1 Read more about NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN NY ESO-1 Japan2001-554422Filed on 2001-01-26
NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN NY ESO-1 Read more about NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN NY ESO-1 European Patent01905152.3Filed on 2001-01-26